Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled glutamate receptor activity	GRM1 GRM4 GRM5 GRM7	1.69e-07	9	123	4	GO:0098988
GeneOntologyMolecularFunction	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity	GRM1 GRM4 GRM5 GRM7	1.69e-07	9	123	4	GO:0001640
GeneOntologyMolecularFunction	glutamate receptor activity	GRM1 GRM4 GRM5 GRM7	2.16e-05	27	123	4	GO:0008066
GeneOntologyMolecularFunction	PLC activating G protein-coupled glutamate receptor activity	GRM1 GRM5	3.76e-05	2	123	2	GO:0001639
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7	1.12e-04	3	123	2	GO:0008389
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETMAR NSD1 EZH1 KMT2A	1.54e-04	44	123	4	GO:0140938
GeneOntologyMolecularFunction	phosphatidylinositol-4-phosphate phosphatase activity	INPP5F FIG4	2.24e-04	4	123	2	GO:0043812
GeneOntologyMolecularFunction	histone H3K36 dimethyltransferase activity	SETMAR NSD1	2.24e-04	4	123	2	GO:0140954
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration	GRM1 GRM5	2.24e-04	4	123	2	GO:0099583
GeneOntologyMolecularFunction	group III metabotropic glutamate receptor activity	GRM4 GRM7	2.24e-04	4	123	2	GO:0001642
GeneOntologyMolecularFunction	G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential	GRM1 GRM5	3.72e-04	5	123	2	GO:0099530
GeneOntologyMolecularFunction	histone modifying activity	KDM3A SETMAR NSD1 PCGF3 EZH1 BAZ1A KMT2A	5.48e-04	229	123	7	GO:0140993
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETMAR NSD1 EZH1 KMT2A	8.24e-04	68	123	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETMAR NSD1 EZH1 KMT2A	8.70e-04	69	123	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	SETMAR NSD1 EZH1 KMT2A	9.69e-04	71	123	4	GO:0042054
GeneOntologyMolecularFunction	spectrin binding	GBP1 GBP2 SPTBN4	1.19e-03	34	123	3	GO:0030507
GeneOntologyMolecularFunction	protein kinase activity	RIPK3 NEK10 MATK ROR2 PAK6 CDC42BPB TNNI3K NEK1 NRBP2 FER TSSK1B	1.21e-03	600	123	11	GO:0004672
GeneOntologyMolecularFunction	metallopeptidase activity	CPM ADAMTS7 LTA4H KEL ADAM2 MMP14	1.51e-03	200	123	6	GO:0008237
GeneOntologyMolecularFunction	phosphatidylinositol phosphate 4-phosphatase activity	INPP5F FIG4	1.64e-03	10	123	2	GO:0034596
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	GRM1 GRM4 GRM5 GRM7	1.39e-07	9	121	4	GO:0007196
GeneOntologyBiologicalProcess	G protein-coupled glutamate receptor signaling pathway	GRM1 GRM4 GRM5 GRM7	1.94e-06	16	121	4	GO:0007216
GeneOntologyBiologicalProcess	glutamate receptor signaling pathway	GRM1 GRM4 GRM5 GRM7 TIAM1	2.48e-05	59	121	5	GO:0007215
GeneOntologyBiologicalProcess	learning	PAK6 IDUA GRM4 GRM5 GRM7 KMT2A SORCS3 ADAM2	3.63e-05	212	121	8	GO:0007612
GeneOntologyCellularComponent	peroxisome	NUDT19 SZT2 VWA8 ISOC1 AGPS ABCD2	3.98e-04	162	123	6	GO:0005777
GeneOntologyCellularComponent	microbody	NUDT19 SZT2 VWA8 ISOC1 AGPS ABCD2	3.98e-04	162	123	6	GO:0042579
GeneOntologyCellularComponent	host intracellular region	GBP1 GBP2	5.07e-04	6	123	2	GO:0043656
GeneOntologyCellularComponent	host cell cytoplasm	GBP1 GBP2	5.07e-04	6	123	2	GO:0030430
GeneOntologyCellularComponent	host cell part	GBP1 GBP2	5.07e-04	6	123	2	GO:0033643
GeneOntologyCellularComponent	host intracellular part	GBP1 GBP2	5.07e-04	6	123	2	GO:0033646
GeneOntologyCellularComponent	host cell cytoplasm part	GBP1 GBP2	5.07e-04	6	123	2	GO:0033655
GeneOntologyCellularComponent	symbiont-containing vacuole	GBP1 GBP2	5.07e-04	6	123	2	GO:0020003
GeneOntologyCellularComponent	symbiont-containing vacuole membrane	GBP1 GBP2	5.07e-04	6	123	2	GO:0020005
GeneOntologyCellularComponent	symbiont cell surface	GBP1 GBP2	9.40e-04	8	123	2	GO:0106139
GeneOntologyCellularComponent	centriolar satellite	SPAG9 CCDC13 NEK1 G6PD WDR62	9.66e-04	128	123	5	GO:0034451
GeneOntologyCellularComponent	lysosome	SZT2 HYAL1 PSMD1 SPG11 SPAG9 IDUA ANKRD27 KLHL22 EPG5 HGS LAMP3 SLC35F6 VTI1B	9.89e-04	811	123	13	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	SZT2 HYAL1 PSMD1 SPG11 SPAG9 IDUA ANKRD27 KLHL22 EPG5 HGS LAMP3 SLC35F6 VTI1B	9.89e-04	811	123	13	GO:0000323
GeneOntologyCellularComponent	other organism part	GBP1 GBP2	1.20e-03	9	123	2	GO:0044217
GeneOntologyCellularComponent	adherens junction	AHI1 SPTBN4 FER CTNNA2 MPP7 CDH18	1.61e-03	212	123	6	GO:0005912
Domain	GPCR_3_mtglu_rcpt	GRM1 GRM4 GRM5 GRM7	1.08e-07	8	119	4	IPR000162
Domain	NCD3G	GRM1 GRM4 GRM5 GRM7	1.07e-06	13	119	4	PF07562
Domain	GPCR_3_9-Cys_dom	GRM1 GRM4 GRM5 GRM7	1.07e-06	13	119	4	IPR011500
Domain	GPCR_3_CS	GRM1 GRM4 GRM5 GRM7	1.49e-06	14	119	4	IPR017979
Domain	GPCR_3	GRM1 GRM4 GRM5 GRM7	8.62e-06	21	119	4	IPR000337
Domain	7tm_3	GRM1 GRM4 GRM5 GRM7	1.05e-05	22	119	4	PF00003
Domain	G_PROTEIN_RECEP_F3_2	GRM1 GRM4 GRM5 GRM7	1.05e-05	22	119	4	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GRM1 GRM4 GRM5 GRM7	1.05e-05	22	119	4	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GRM1 GRM4 GRM5 GRM7	1.05e-05	22	119	4	PS00979
Domain	G_PROTEIN_RECEP_F3_4	GRM1 GRM4 GRM5 GRM7	1.05e-05	22	119	4	PS50259
Domain	GPCR_3_C	GRM1 GRM4 GRM5 GRM7	1.05e-05	22	119	4	IPR017978
Domain	GluR_Homer-bdg	GRM1 GRM5	4.03e-05	2	119	2	PF10606
Domain	Metabotropic_Glu_rcpt_Homer-bd	GRM1 GRM5	4.03e-05	2	119	2	IPR019588
Domain	GPCR_3_mtglu_rcpt_1	GRM1 GRM5	4.03e-05	2	119	2	IPR001256
Domain	GluR_Homer-bdg	GRM1 GRM5	4.03e-05	2	119	2	SM01229
Domain	GPCR_3_mtglu_rcpt_5	GRM1 GRM5	4.03e-05	2	119	2	IPR000202
Domain	ANF_lig-bd_rcpt	GRM1 GRM4 GRM5 GRM7	8.79e-05	37	119	4	IPR001828
Domain	ANF_receptor	GRM1 GRM4 GRM5 GRM7	8.79e-05	37	119	4	PF01094
Domain	Peripla_BP_I	GRM1 GRM4 GRM5 GRM7	1.08e-04	39	119	4	IPR028082
Domain	PC_rep	PSMD1 ANAPC1	1.20e-04	3	119	2	PF01851
Domain	Proteasome/cyclosome_rpt	PSMD1 ANAPC1	1.20e-04	3	119	2	IPR002015
Domain	SET	SETMAR NSD1 EZH1 KMT2A	1.32e-04	41	119	4	PF00856
Domain	Post-SET_dom	SETMAR NSD1 KMT2A	1.33e-04	16	119	3	IPR003616
Domain	PostSET	SETMAR NSD1 KMT2A	1.33e-04	16	119	3	SM00508
Domain	POST_SET	SETMAR NSD1 KMT2A	1.33e-04	16	119	3	PS50868
Domain	Kinase-like_dom	RIPK3 NEK10 MATK ROR2 PAK6 ARHGAP35 CDC42BPB TNNI3K NEK1 NRBP2 FER TSSK1B	1.79e-04	542	119	12	IPR011009
Domain	SET	SETMAR NSD1 EZH1 KMT2A	2.08e-04	46	119	4	SM00317
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7	2.40e-04	4	119	2	IPR008067
Domain	SET_dom	SETMAR NSD1 EZH1 KMT2A	2.88e-04	50	119	4	IPR001214
Domain	SET	SETMAR NSD1 EZH1 KMT2A	2.88e-04	50	119	4	PS50280
Domain	Prot_kinase_dom	RIPK3 NEK10 MATK ROR2 PAK6 CDC42BPB TNNI3K NEK1 NRBP2 FER TSSK1B	2.93e-04	489	119	11	IPR000719
Domain	PROTEIN_KINASE_DOM	RIPK3 NEK10 MATK ROR2 PAK6 CDC42BPB TNNI3K NEK1 NRBP2 FER TSSK1B	3.14e-04	493	119	11	PS50011
Domain	Sortilin_C	SORCS1 SORCS3	3.98e-04	5	119	2	PF15901
Domain	Sortilin-Vps10	SORCS1 SORCS3	3.98e-04	5	119	2	PF15902
Domain	VPS10	SORCS1 SORCS3	3.98e-04	5	119	2	IPR006581
Domain	Syja_N	INPP5F FIG4	3.98e-04	5	119	2	PF02383
Domain	Sortilin_N	SORCS1 SORCS3	3.98e-04	5	119	2	IPR031778
Domain	Sortilin_C	SORCS1 SORCS3	3.98e-04	5	119	2	IPR031777
Domain	VPS10	SORCS1 SORCS3	3.98e-04	5	119	2	SM00602
Domain	SAC	INPP5F FIG4	3.98e-04	5	119	2	PS50275
Domain	SAC_dom	INPP5F FIG4	3.98e-04	5	119	2	IPR002013
Domain	PROTEIN_KINASE_ATP	RIPK3 NEK10 MATK ROR2 PAK6 CDC42BPB TNNI3K NEK1 FER TSSK1B	7.13e-04	459	119	10	PS00107
Domain	Protein_kinase_ATP_BS	RIPK3 NEK10 MATK PAK6 CDC42BPB TNNI3K NEK1 FER TSSK1B	7.22e-04	379	119	9	IPR017441
Domain	PKD	SORCS1 SORCS3	8.28e-04	7	119	2	PF00801
Domain	Sialidases	SORCS1 SORCS3	1.41e-03	9	119	2	IPR011040
Domain	GBP_C	GBP1 GBP2	1.75e-03	10	119	2	PF02841
Domain	G_GB1_RHD3_dom	GBP1 GBP2	2.13e-03	11	119	2	IPR030386
Domain	Guanylate-bd_N	GBP1 GBP2	2.13e-03	11	119	2	IPR015894
Domain	PKD	SORCS1 SORCS3	2.13e-03	11	119	2	PS50093
Domain	PKD_dom	SORCS1 SORCS3	2.13e-03	11	119	2	IPR000601
Domain	Guanylate-bd_C	GBP1 GBP2	2.13e-03	11	119	2	IPR003191
Domain	GBP	GBP1 GBP2	2.13e-03	11	119	2	PF02263
Domain	-	SORCS1 SORCS3	2.13e-03	11	119	2	2.60.40.670
Domain	G_GB1_RHD3	GBP1 GBP2	2.13e-03	11	119	2	PS51715
Domain	Znf_FYVE_PHD	KDM3A NSD1 BAZ1A HGS KMT2A	2.51e-03	147	119	5	IPR011011
Domain	PROTEIN_KINASE_TYR	NEK10 MATK ROR2 FER	3.44e-03	97	119	4	PS00109
Domain	Tyr_kinase_AS	NEK10 MATK ROR2 FER	3.44e-03	97	119	4	IPR008266
Domain	ZINC_PROTEASE	ADAMTS7 LTA4H KEL MMP14	3.57e-03	98	119	4	PS00142
Domain	Ig_E-set	A2M FLNC PKHD1L1 SNRNP200	4.41e-03	104	119	4	IPR014756
Domain	PBD	PAK6 CDC42BPB	4.56e-03	16	119	2	SM00285
Domain	PBD	PAK6 CDC42BPB	5.14e-03	17	119	2	PF00786
Domain	HATPase_c	PMS1 MORC4	5.76e-03	18	119	2	SM00387
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM1 GRM4 GRM5 GRM7	2.83e-06	15	98	4	M39442
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM1 GRM4 GRM5 GRM7	2.83e-06	15	98	4	MM15845
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	GRM1 GRM4 GRM5 GRM7	1.22e-04	37	98	4	MM15067
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	GRM1 GRM4 GRM5 GRM7	1.50e-04	39	98	4	M793
Pubmed	Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion.	GRM1 GRM4 GRM5 GRM7	5.34e-09	7	124	4	9920659
Pubmed	Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors.	GRM1 GRM4 GRM5 GRM7	3.18e-08	10	124	4	9069281
Pubmed	The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors.	GRM1 GRM5 GRM7	4.42e-08	3	124	3	16024054
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	MATK ROR2 PAK6 PCGF3 KLHL22 TNNI3K SF3B3 DTX4 FER TSSK1B	9.62e-07	372	124	10	22939624
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	FLNC RARS1 COQ6 RPS15 ISOC1 PSMD1 PSMD3 EPG5 ERLIN2 SF3B3 KMT2A LTA4H G6PD SNRNP200	1.21e-06	807	124	14	30575818
Pubmed	Glutamate can act as a signaling molecule in mouse preimplantation embryos†.	GRM1 GRM4 GRM5 GRM7	1.55e-06	24	124	4	35746896
Pubmed	Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways.	MATK RPS15 PAK6 NEK1	1.84e-06	25	124	4	24947832
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	HECTD4 KCNAB2 NSD1 GRM1 GRM4 GRM5 CDC42BPB SPTBN4 CCDC13 FARSA ANAPC1 KIF5A CTNNA2 NEURL4 NIPBL	1.86e-06	963	124	15	28671696
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	A2M FLNC PLOD3 RPS15 PSMD1 PSMD3 SPAG9 TRMT10C ERLIN2 TTC17 KIF5A MMP14 G6PD SNRNP200 MPP7	2.14e-06	974	124	15	28675297
Pubmed	The repertoire of olfactory C family G protein-coupled receptors in zebrafish: candidate chemosensory receptors for amino acids.	GRM1 GRM4 GRM7	5.21e-06	10	124	3	17156446
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PMS1 PLOD3 PDPR RPS15 PSMD1 PSMD3 SPAG9 CDC42BPB TRMT10C TIAM1 HGS RELL1 G6PD NEURL4 MPP7	5.25e-06	1049	124	15	27880917
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NUDT19 PMS1 PLOD3 PDPR VWA8 ROR2 SPG11 CDC42BPB TRMT10C SF3B3 TIAM1 HGS TTC17 RELL1 SNRNP200 NEURL4 WDR62 MPP7	5.71e-06	1487	124	18	33957083
Pubmed	Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.	KDM3A NSD1 EZH1 KMT2A	5.81e-06	33	124	4	26864203
Pubmed	WDR62 is required for centriole duplication in spermatogenesis and manchette removal in spermiogenesis.	RFX2 TDRD6 MAPKBP1 WDR62	1.03e-05	38	124	4	34059773
Pubmed	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	PDE1A RARS1 ARHGAP35	1.23e-05	13	124	3	21844884
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	USP18 KDM3A NSD1 CPM INPP5F PCGF3 LRP1B CDC42BPB NEK1 KMT2A ADAM2 MMP14	1.25e-05	730	124	12	34857952
Pubmed	Involvement of group I metabotropic glutamate receptors and glutamate transporters in the slow excitatory synaptic transmission in the spinal cord dorsal horn.	GRM1 GRM5	1.26e-05	2	124	2	18554818
Pubmed	Cyclic ADP ribose-dependent Ca2+ release by group I metabotropic glutamate receptors in acutely dissociated rat hippocampal neurons.	GRM1 GRM5	1.26e-05	2	124	2	22028929
Pubmed	Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.	GRM1 GRM5	1.26e-05	2	124	2	9185557
Pubmed	Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.	CYP2A6 CYP2A7	1.26e-05	2	124	2	12325023
Pubmed	Dimerization and its role in GMP formation by human guanylate binding proteins.	GBP1 GBP2	1.26e-05	2	124	2	20923658
Pubmed	Group 1 metabotropic glutamate receptors 1 and 5 form a protein complex in mouse hippocampus and cortex.	GRM1 GRM5	1.26e-05	2	124	2	27392515
Pubmed	SORCS1 and SORCS3 control energy balance and orexigenic peptide production.	SORCS1 SORCS3	1.26e-05	2	124	2	29440124
Pubmed	Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.	GRM4 GRM7	1.26e-05	2	124	2	19351574
Pubmed	Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia.	GRM1 GRM5	1.26e-05	2	124	2	28982591
Pubmed	CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.	CYP2A6 CYP2A7	1.26e-05	2	124	2	16636685
Pubmed	Neutrophil-derived glutamate regulates vascular endothelial barrier function.	GRM1 GRM4	1.26e-05	2	124	2	11847215
Pubmed	mGluR₁,5 activation improves network asynchrony and GABAergic synapse attenuation in the amygdala: implication for anxiety-like behavior in DBA/2 mice.	GRM1 GRM5	1.26e-05	2	124	2	22681774
Pubmed	Identification and characterization of a sac domain-containing phosphoinositide 5-phosphatase.	INPP5F FIG4	1.26e-05	2	124	2	11274189
Pubmed	Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism.	GRM4 GRM5	1.26e-05	2	124	2	25747602
Pubmed	Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.	GRM1 GRM5	1.26e-05	2	124	2	18035501
Pubmed	The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.	CYP2A6 CYP2A7	1.26e-05	2	124	2	2322567
Pubmed	Determination of group I metabotropic glutamate receptor subtypes involved in the frequency of epileptiform activity in vitro using mGluR1 and mGluR5 mutant mice.	GRM1 GRM5	1.26e-05	2	124	2	12623213
Pubmed	Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation.	GRM1 GRM5	1.26e-05	2	124	2	15184389
Pubmed	mGluR1,5 activation protects cortical astrocytes and GABAergic neurons from ischemia-induced impairment.	GRM1 GRM5	1.26e-05	2	124	2	23280324
Pubmed	Expression and alternative splicing of the cytochrome P-450 CYP2A7.	CYP2A6 CYP2A7	1.26e-05	2	124	2	7864805
Pubmed	Differential expression of interferon inducible protein: Guanylate binding protein (GBP1 & GBP2) in severe dengue.	GBP1 GBP2	1.26e-05	2	124	2	36460216
Pubmed	Metabotropic glutamate receptors in the main olfactory bulb drive granule cell-mediated inhibition.	GRM1 GRM5	1.26e-05	2	124	2	17093122
Pubmed	Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.	GRM1 GRM5	1.26e-05	2	124	2	11591458
Pubmed	Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.	PSMD1 PSMD3	1.26e-05	2	124	2	33712704
Pubmed	A negative feedback loop between JNK-associated leucine zipper protein and TGF-β1 regulates kidney fibrosis.	SPAG9 CDH16	1.26e-05	2	124	2	32504044
Pubmed	Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons.	GRM4 GRM5	1.26e-05	2	124	2	18174899
Pubmed	Identification and characterization of SorCS, a third member of a novel receptor family.	SORCS1 SORCS3	1.26e-05	2	124	2	10600506
Pubmed	Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors.	GRM1 GRM5	1.26e-05	2	124	2	33279506
Pubmed	Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy.	GRM1 GRM4	1.26e-05	2	124	2	17446080
Pubmed	Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins.	GBP1 GBP2	1.26e-05	2	124	2	23086406
Pubmed	In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis.	GRM1 GRM5	1.26e-05	2	124	2	31102766
Pubmed	26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.	PSMD1 PSMD3	1.26e-05	2	124	2	34572038
Pubmed	Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine.	GBP1 GBP2	1.26e-05	2	124	2	20483731
Pubmed	mGluR5 Is Substitutable for mGluR1 in Cerebellar Purkinje Cells for Motor Coordination, Developmental Synapse Elimination, and Motor Learning.	GRM1 GRM5	1.26e-05	2	124	2	35805089
Pubmed	JLP/Foxk1/N-cadherin axis fosters a partial epithelial-mesenchymal transition state in epithelial tubular cells.	SPAG9 CDH16	1.26e-05	2	124	2	37013185
Pubmed	Corticostriatal LTP requires combined mGluR1 and mGluR5 activation.	GRM1 GRM5	1.26e-05	2	124	2	12559117
Pubmed	Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression.	GRM1 GRM5	1.26e-05	2	124	2	31540330
Pubmed	Differential distribution of group I metabotropic glutamate receptors in developing human cortex.	GRM1 GRM5	1.26e-05	2	124	2	20149785
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RARS1 VWA8 KCNAB2 ISOC1 PSMD1 PSMD3 ARHGAP35 GRM5 LRP1B CDC42BPB TRMT10C ERLIN2 KCNQ5 CTNNA2 POLD3	1.39e-05	1139	124	15	36417873
Pubmed	Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.	GRM1 GRM4 GRM5	1.56e-05	14	124	3	21795692
Pubmed	Proteomic and Interactome Approaches Reveal PAK4, PHB-2, and 14-3-3η as Targets of Overactivated Cdc42 in Cellular Responses to Genomic Instability.	PMS1 FLNC RARS1 RPS15 PSMD3 CDC42BPB G6PD	1.71e-05	225	124	7	31478661
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	NUDT19 FLNC PSMD1 PSMD3 INPP5F ERLIN2 SNRNP200 NEURL4	1.75e-05	313	124	8	38270169
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	FLNC PSMD1 PSMD3 SPAG9 KIF5A G6PD SNRNP200	2.03e-05	231	124	7	36597993
Pubmed	Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.	GRM1 GRM4 GRM5 GRM7	2.05e-05	45	124	4	25979088
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNC RARS1 RPS15 ISOC1 PSMD1 PSMD3 AGPS IFI16 ANKRD27 SF3B3 BAZ1A POLD3 MMP14 G6PD SNRNP200 NIPBL	2.63e-05	1353	124	16	29467282
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	KDM3A NSD1 EZH1 KMT2A	2.88e-05	49	124	4	34368113
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	FLNC RARS1 RPS15 PSMD1 CDC42BPB SORCS1 FARSA TRMT10C SF3B3 ANAPC1 SNRNP200 WDR62	3.41e-05	809	124	12	32129710
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	AHI1 CTNNA2 NIPBL	3.47e-05	18	124	3	33323119
Pubmed	Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.	CYP2A6 G6PD	3.77e-05	3	124	2	18068688
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7	3.77e-05	3	124	2	31645370
Pubmed	CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.	CYP2A6 CYP2A7	3.77e-05	3	124	2	11960914
Pubmed	Calcineurin inhibitor protein (CAIN) attenuates Group I metabotropic glutamate receptor endocytosis and signaling.	GRM1 GRM5	3.77e-05	3	124	2	19717561
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7	3.77e-05	3	124	2	3346244
Pubmed	Guanylate binding proteins facilitate caspase-11-dependent pyroptosis in response to type 3 secretion system-negative Pseudomonas aeruginosa.	GBP1 GBP2	3.77e-05	3	124	2	30062052
Pubmed	The binding of Varp to VAMP7 traps VAMP7 in a closed, fusogenically inactive conformation.	ANKRD27 VTI1B	3.77e-05	3	124	2	23104059
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7	3.77e-05	3	124	2	2733794
Pubmed	Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages.	GBP1 GBP2	3.77e-05	3	124	2	26416908
Pubmed	Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices.	GRM1 GRM5	3.77e-05	3	124	2	12364493
Pubmed	SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting mGluR1/5.	GRM1 GRM5	3.77e-05	3	124	2	31270711
Pubmed	Guanylate-binding protein 2 orchestrates innate immune responses against murine norovirus and is antagonized by the viral protein NS7.	GBP1 GBP2	3.77e-05	3	124	2	32354743
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7	3.77e-05	3	124	2	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7	3.77e-05	3	124	2	8188299
Pubmed	Amyloidosis causes downregulation of SorLA, SorCS1 and SorCS3 expression in mice.	SORCS1 SORCS3	3.77e-05	3	124	2	31095505
Pubmed	GTPase properties of the interferon-induced human guanylate-binding protein 2.	GBP1 GBP2	3.77e-05	3	124	2	8706832
Pubmed	Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.	GRM1 GRM5	3.77e-05	3	124	2	20410124
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7	3.77e-05	3	124	2	8484736
Pubmed	Guanylate binding proteins contained in the murine chromosome 3 are important to control mycobacterial infection.	GBP1 GBP2	3.77e-05	3	124	2	32620042
Pubmed	[Guanylate-binding protein 2 regulates the maturation of mouse dendritic cells induced by β-glucan].	GBP1 GBP2	3.77e-05	3	124	2	29089068
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7	3.77e-05	3	124	2	8250953
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7	3.77e-05	3	124	2	2703500
Pubmed	Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication.	GBP1 GBP2	3.77e-05	3	124	2	23248289
Pubmed	Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP.	GBP1 GBP2	3.77e-05	3	124	2	1715024
Pubmed	GBP1 Facilitates Indoleamine 2,3-Dioxygenase Extracellular Secretion to Promote the Malignant Progression of Lung Cancer.	GBP1 GBP2	3.77e-05	3	124	2	33552086
Pubmed	The three sorCS genes are differentially expressed and regulated by synaptic activity.	SORCS1 SORCS3	3.77e-05	3	124	2	15009648
Pubmed	Two families of GTPases dominate the complex cellular response to IFN-gamma.	GBP1 GBP2	3.77e-05	3	124	2	9862701
Pubmed	The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation.	GBP1 GBP2	3.77e-05	3	124	2	11726669
Pubmed	Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit/hyperactivity disorder and functional exploration of risk loci.	GRM4 GRM7	3.77e-05	3	124	2	33068816
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7	3.77e-05	3	124	2	1417950
Pubmed	GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis.	GBP1 GBP2	3.77e-05	3	124	2	38636926
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7	3.77e-05	3	124	2	24045421
Pubmed	Hidden Twins: SorCS Neuroreceptors Form Stable Dimers.	SORCS1 SORCS3	3.77e-05	3	124	2	28827148
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7	3.77e-05	3	124	2	32987105
Pubmed	Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival.	GRM4 GRM5	3.77e-05	3	124	2	30488581
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7	3.77e-05	3	124	2	22217847
Cytoband	10q23-q25	SORCS1 SORCS3	4.33e-05	4	124	2	10q23-q25
Cytoband	19q13.11	NUDT19 ANKRD27 RHPN2	2.51e-04	45	124	3	19q13.11
Cytoband	8p11.2	ERLIN2 ADAM2	6.45e-04	14	124	2	8p11.2
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM1 GRM4 GRM5 GRM7	2.33e-08	8	79	4	281
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD1 EZH1 KMT2A	4.36e-04	34	79	3	487
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	GRM1 GRM5 GRM7 FER POLD3	1.18e-03	181	79	5	694
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GRM1 GRM5 GRM7 LRP1B SORCS1 SORCS3 CTNNA2 CDH18	5.17e-09	139	123	8	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GRM5 GRM7 LRP1B C1orf141 SORCS3 CTNNA2 CDH18	2.04e-07	150	123	7	0205318a870e091add66ee4305747dda9f51510d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	A2M KDM3A ZNF407 SPG11 PCGF3 HGS MMP14	4.59e-07	169	123	7	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	A2M KDM3A ZNF407 SPG11 PCGF3 HGS MMP14	4.59e-07	169	123	7	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOK6 SZT2 GRM4 GRM7 CCDC13 KEL CDH18	8.74e-07	186	123	7	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 MATK KCNAB2 PAK6 GRM1 GRM5 SPTBN4	1.12e-06	193	123	7	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 MATK KCNAB2 PAK6 GRM1 GRM5 SPTBN4	1.12e-06	193	123	7	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 MATK KCNAB2 PAK6 GRM1 GRM5 SPTBN4	1.12e-06	193	123	7	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	AHI1 RFX2 SORCS1 KCNQ5 SORCS3 MPP7 CDH18	1.42e-06	200	123	7	dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	AHI1 RFX2 SORCS1 KCNQ5 SORCS3 MPP7 CDH18	1.42e-06	200	123	7	d92d51021ab6d78e9c8f89f7c150181004dcbcbd
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	AHI1 RFX2 SORCS1 KCNQ5 SORCS3 MPP7 CDH18	1.42e-06	200	123	7	cbbb9044283ff9ab63bbfc24d7a9f006b1372705
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R\|Neuronal / cells hierarchy compared to all cells using T-Statistic	AHI1 RFX2 SORCS1 KCNQ5 SORCS3 MPP7 CDH18	1.42e-06	200	123	7	a3e36bbeed19431d07bc205f14f4e0f12bd8f730
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GRM1 GRM5 GRM7 LRP1B CTNNA2 CDH18	3.54e-06	148	123	6	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	USP18 GBP1 GRM5 ADAM2 TDRD6 CDH18	6.39e-06	164	123	6	362c16ed7fb37bf16601fd5e059d3f3e2ed692b4
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	SAMD8 SPAG9 EZH1 LRP1B FCHSD2 KMT2A	9.89e-06	177	123	6	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 PDE1A ARHGAP40 LRP1B GRHL1	1.02e-05	178	123	6	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M ROR2 GRM4 C1orf141 FBLN1 LAMP3	1.05e-05	179	123	6	7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A VWA8 NEK10 SLC43A1 CPM F11	1.09e-05	180	123	6	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	USP18 GBP1 GBP2 IFI16 BAZ1A LAMP3	1.19e-05	183	123	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M GRM1 LRP1B PKHD1L1 SORCS1 KIF5A	1.23e-05	184	123	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M GRM1 LRP1B PKHD1L1 SORCS1 KIF5A	1.23e-05	184	123	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M GRM1 LRP1B PKHD1L1 SORCS1 KIF5A	1.23e-05	184	123	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	BAL-Severe-Myeloid-Macrophage\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	ae966929fb5bbb08ffcbac76cb21941638727f55
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	3beebaa92275086b1fae5f8c0c3d54016c5ba2aa
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	ceff11cfa679147ccfd0a0f8079e697a6bea34d9
ToppCell	BAL-Severe-Myeloid-Macrophage\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	9aea5ed8f9cee5ee933891203aac7adb85d68201
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	42939b294ea3e871274d8b73124c850dc1904fd2
ToppCell	Severe_COVID-19-Myeloid-transitional_Macro\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	f7ef0d7740b4cfedc38846e802898c402dc411fd
ToppCell	BAL-Severe-Myeloid-Macrophage-transitional_Macro\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M KCNAB2 CPM SLC35F6 LTA4H MMP14	1.27e-05	185	123	6	7a3612520ae4f0cd61480eadba31eecce001419d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NEK10 SLC43A1 CPM LRP1B F11	1.35e-05	187	123	6	85e58a312fc325e4063a2d250666b99b8f99beb6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A GRM1 GRM7 SORCS1 KCNQ5 CDH18	1.39e-05	188	123	6	50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A GRM1 GRM7 LRP1B F11 SORCS3	1.39e-05	188	123	6	3cee9916399e2e7580cecbcbb27424a71e7e7ac0
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A GRM7 SORCS1 KCNQ5 MPP7 CDH18	1.43e-05	189	123	6	c3df0e3c50af8f1cfb4d790e668bd7f42b276992
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	USP18 GBP1 GBP2 IFI16 BAZ1A LAMP3	1.52e-05	191	123	6	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	Epithelial_cells-Club_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	CYP2A6 CYP2A7 ARHGAP40 IFI16 GRHL1 DTX4	1.71e-05	195	123	6	b758676abfc4e6930b696d270ecc0ea461b87a54
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2A6 CYP2A7 ARHGAP40 GRM4 GRHL1 DTX4	1.71e-05	195	123	6	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	USP18 GBP1 GBP2 IFI16 BAZ1A LAMP3	1.71e-05	195	123	6	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	droplet-Marrow-BM-1m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP18 RIPK3 PSMD1 PSMD3 SF3B3 BAZ1A	1.71e-05	195	123	6	637b06ef3967b03f7165d102d316e8b7161a817d
ToppCell	Mild-CD4+_T_activated\|Mild / Disease group and Cell class	USP18 GBP1 GBP2 IFI16 BAZ1A LAMP3	1.76e-05	196	123	6	daa1c3322d81e649161e889e1d78451d2d425d09
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOK6 AHI1 GRM5 SPTBN4 KCNQ5 CDH18	1.87e-05	198	123	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP18 GBP1 SPAG9 IFI16 KMT2A NIPBL	1.97e-05	200	123	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NDST1 PDE1A LRP1B RELL1 CDH18	3.07e-05	130	123	5	05d5a73acf1d7f75a79876b1a06d27c74a89b8a4
ToppCell	COVID-19-kidney-Technical/muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GRM5 GRM7 LRP1B CTNNA2 CDH18	4.22e-05	139	123	5	13247bcb21c57c808657e0f543d6f134eeea7cc1
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe-9\|TCGA-Kidney / Sample_Type by Project: Shred V9	SETMAR ABHD3 SPTBN4 ADAM2 CTNNA2	4.22e-05	139	123	5	a93b861906d7f01ff715084f99152ec83529f8b3
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe\|TCGA-Kidney / Sample_Type by Project: Shred V9	SETMAR ABHD3 SPTBN4 ADAM2 CTNNA2	4.37e-05	140	123	5	bc5bed94c33129391ca35791febb55cc4cdff989
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	GRM1 GRM5 GRM7 CTNNA2 CDH18	5.34e-05	146	123	5	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH7B INPP5F GRM1 TIAM1 SORCS3	5.88e-05	149	123	5	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	USP18 GBP1 GBP2 IFI16 LAMP3	6.46e-05	152	123	5	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	GRM5 GRM7 KCNQ5 CTNNA2 CDH18	7.99e-05	159	123	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1B PKHD1L1 SORCS1 CTNNA2 TDRD6	8.23e-05	160	123	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1B PKHD1L1 SORCS1 CTNNA2 TDRD6	8.23e-05	160	123	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 PDE1A ARHGAP40 GRHL1	8.73e-05	162	123	5	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	GRM7 C1orf141 KCNQ5 CTNNA2 CDH18	8.98e-05	163	123	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SZT2 CPM INPP5F TIAM1 BFSP2	8.98e-05	163	123	5	9f5facfa1864eb63e2f8022ad7379d9252b7a254
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	PDE1A PKHD1L1 DTX4 EFCAB7 MPP7	8.98e-05	163	123	5	961c3a1303108afd680365466045f3460a30a7b0
ToppCell	facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M DOK6 ABHD3 NRBP2 KEL	9.52e-05	165	123	5	4f95c2fe5ab4416c736fe0d1936695a2b26777eb
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M CPM LRP1B ADAMTS7 FER	9.52e-05	165	123	5	37615622c736e43260c38016e7c9e565ac97a3e8
ToppCell	facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M DOK6 ABHD3 NRBP2 KEL	9.52e-05	165	123	5	3e913b49a868fdd5589200ae3e9be77c0938ba14
ToppCell	nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M CPM LRP1B ADAMTS7 FER	9.52e-05	165	123	5	640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCell	nucseq-Immune-Hematopoietic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M CPM LRP1B ADAMTS7 FER	9.52e-05	165	123	5	f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCell	ICU-SEP-Lymphocyte-T_NK-dnT\|ICU-SEP / Disease, Lineage and Cell Type	GPAM KCNQ5 ABCD2 MMP14 BFSP2	9.79e-05	166	123	5	96d92316cee20b722fe782db9dafcceb8f2c220b
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	A2M CPM LRP1B ADAMTS7 FER	1.06e-04	169	123	5	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEK10 GRM5 GRM7 CFAP65 CCDC13	1.06e-04	169	123	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	A2M CPM LRP1B ADAMTS7 FER	1.09e-04	170	123	5	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AHI1 GRM7 SORCS1 KCNQ5 KIF5A	1.25e-04	175	123	5	8362a46f5804333baa84cd56d450bc147f372a7e
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AHI1 GRM7 SORCS1 KCNQ5 KIF5A	1.25e-04	175	123	5	8b4c62e608f0ec84e563bbf0ebffe3ed44085298
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PMS1 GRM1 GRM4 KIF5A CDH18	1.25e-04	175	123	5	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 PDE1A ARHGAP40 GRHL1	1.36e-04	178	123	5	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	USP18 GBP1 GBP2 IFI16 LAMP3	1.39e-04	179	123	5	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	(05)_Ciliated-(4)_1wkpi\|(05)_Ciliated / shred by cell type and Timepoint	SAMD8 CFAP65 NRBP2 MAPKBP1 ABCD2	1.43e-04	180	123	5	85fc9b164147b28545e2397d32302eea03ef6346
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A CPM GRM1 LRP1B F11	1.43e-04	180	123	5	eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A CPM GRM1 LRP1B F11	1.43e-04	180	123	5	a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	RFX2 SORCS1 FBLN1 KCNQ5 TIAM1	1.47e-04	181	123	5	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC RIPK3 MATK RFX2 WDR62	1.47e-04	181	123	5	c7f5aedcb74c21fb587a95a16d700e2a38a380ee
ToppCell	facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC RIPK3 MATK RFX2 WDR62	1.47e-04	181	123	5	0ec9621a078d004bbd25a587757d24b5cf162959
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CYP2A6 CYP2A7 ARHGAP40 GRHL1 TSSK1B	1.47e-04	181	123	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A GRM1 GRM7 KCNQ5 MPP7	1.51e-04	182	123	5	14a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCell	HSPCs-Neutro_prog.\|World / Lineage and Cell class	MATK AGPS BAZ1A LTA4H ABCD2	1.51e-04	182	123	5	f2512354b90f55bf4172c28084bf52cf79e41d8a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A GRM1 LRP1B SORCS1 KCNQ5	1.54e-04	183	123	5	c7e94fe3e7669db9304b249979fef7a69c30a143
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A GRM1 LRP1B F11 SPTBN4	1.58e-04	184	123	5	e8238fe58f94b4f5700ab7f343fb06ea61e899a9
ToppCell	Control-CD8+_T_activated\|Control / Disease group and Cell class	USP18 GBP1 IDUA TRMT10C LAMP3	1.58e-04	184	123	5	b86cc48b744b3206880ec1373fe6068e14bf9680
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M PMS1 GRM1 TIAM1 KIF5A	1.63e-04	185	123	5	cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	USP18 GBP1 GBP2 IFI16 BAZ1A	1.63e-04	185	123	5	f30fb9d75cdb757b206312992aaf7485bc900f96
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A VWA8 NEK10 CPM F11	1.63e-04	185	123	5	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SPAG9 SORCS1 TDRD6 MMP14	1.63e-04	185	123	5	29d7ddcb9a2e45f76cd5611f7c52b6df689effd3
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SPAG9 SORCS1 TDRD6 MMP14	1.63e-04	185	123	5	780bdb63ef913a09930063286011c9108381d3a9
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK SPAG9 SORCS1 TDRD6 MMP14	1.63e-04	185	123	5	274b8acccdfe434d14af4cb32fb615c06ec98435
ToppCell	BAL-Control-Myeloid-MoAM-MoAM4-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MATK SPAG9 SORCS1 TDRD6 MMP14	1.63e-04	185	123	5	b640d9ed6a1e6aa595053065bb992efc0402353e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE1A CPM KCNQ5 LTA4H MPP7	1.67e-04	186	123	5	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	GRM7 LRP1B SORCS1 SORCS3 CTNNA2	1.67e-04	186	123	5	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A VWA8 NEK10 CPM F11	1.67e-04	186	123	5	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRM7 SORCS1 KCNQ5 MPP7 CDH18	1.67e-04	186	123	5	bdbe290f81106a53c8c30a92fbb385597c62b2ac
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A VWA8 NEK10 CPM F11	1.67e-04	186	123	5	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATK KCNAB2 PAK6 GRM5 SPTBN4	1.67e-04	186	123	5	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HYAL1 MATK ROR2 GBP2 MMP14	1.67e-04	186	123	5	c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A GRM7 SORCS1 KCNQ5 CDH18	1.71e-04	187	123	5	f18628ffc7ff7c762b8339ba8822cf0c3157f469
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A NEK10 SLC43A1 CPM F11	1.71e-04	187	123	5	52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A GRM1 LRP1B F11 SORCS3	1.71e-04	187	123	5	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	normal_Lung-Myeloid_cells-pDCs\|normal_Lung / Location, Cell class and cell subclass	USP18 INPP5F FCHSD2 KCNQ5 HGS	1.71e-04	187	123	5	d36751372fd40a46441f07735c9c3c5dcb503f24
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	USP18 GBP1 GBP2 IFI16 LAMP3	1.75e-04	188	123	5	6f8946d4710f6e32c937213f99b790b098b8819c
Drug	cis-MCG-I	GRM1 GRM4 GRM5 GRM7	5.58e-08	8	123	4	CID003035584
Drug	mM PEP	GRM1 GRM4 GRM5 GRM7	1.00e-07	9	123	4	CID005311462
Drug	AC1N21PP	GRM1 GRM4 GRM5 GRM7	1.00e-07	9	123	4	CID004014619
Drug	1,3-cyclopentanedicarboxylic acid	GRM1 GRM4 GRM5 GRM7	1.00e-07	9	123	4	CID000107216
Drug	NS-105	GRM1 GRM4 GRM5 GRM7	1.66e-07	10	123	4	CID000198695
Drug	cyclobutylene AP5	GRM1 GRM4 GRM5 GRM7	2.60e-07	11	123	4	CID000126582
Drug	Mspg	GRM1 GRM4 GRM5 GRM7	5.58e-07	13	123	4	CID003964410
Drug	MSOPPE	GRM1 GRM4 GRM5 GRM7	5.58e-07	13	123	4	CID005311463
Drug	AC1NSKBB	GRM1 GRM4 GRM5 GRM7	5.58e-07	13	123	4	CID005311256
Drug	Cbpg	GRM1 GRM4 GRM5	6.13e-07	4	123	3	CID005311040
Drug	MTPG	GRM1 GRM4 GRM5 GRM7	7.79e-07	14	123	4	CID005311456
Drug	2-methyl-6-styrylpyridine	GRM1 GRM4 GRM5 GRM7	7.79e-07	14	123	4	CID000235382
Drug	Luteolin [491-70-3]; Down 200; 14uM; PC3; HT_HG-U133A	AHI1 ARHGAP35 IFI16 NEK1 FCHSD2 TIAM1 BAZ1A MMP14 NIPBL	9.85e-07	191	123	9	6658_DN
Drug	ethylglutamate	GRM1 GRM4 GRM5 GRM7	1.40e-06	16	123	4	CID000014241
Drug	2-PMPA	GRM1 GRM4 GRM5 GRM7	1.40e-06	16	123	4	CID010130754
Drug	3HPG	GRM1 GRM4 GRM5 GRM7	1.83e-06	17	123	4	CID000001217
Drug	acromelic acid A	GRM1 GRM4 GRM5 GRM7	2.34e-06	18	123	4	CID000108086
Drug	aminocyclopentane	GRM1 GRM4 GRM5 GRM7	2.95e-06	19	123	4	CID000002906
Drug	AC1MBZ3L	GRM1 GRM4 GRM5	3.04e-06	6	123	3	CID002733524
Drug	4-carboxy-3-hydroxyphenylglycine	GRM1 GRM4 GRM5 GRM7	3.67e-06	20	123	4	CID000001297
Drug	3,4-dihydroxyphenylglycine	GRM1 GRM4 GRM5 GRM7	4.52e-06	21	123	4	CID000027915
Drug	phorbol 12,13-diacetate	SPAG9 GRM1 GRM4 GRM5 GRM7	6.03e-06	48	123	5	CID000072293
Drug	MSOP	GRM1 GRM4 GRM5 GRM7	6.63e-06	23	123	4	CID003964633
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	RARS1 ABHD3 SPAG9 CPM IFI16 FIG4 LTA4H G6PD	7.89e-06	186	123	8	1612_UP
Drug	RS)-2-chloro-5-hydroxyphenylglycine	GRM1 GRM4 GRM5 GRM7	7.93e-06	24	123	4	CID003645780
Drug	AC1NQH9B	GRM1 GRM4 GRM5 GRM7	1.11e-05	26	123	4	CID005221504
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	A2M KCNAB2 KLHL22 FBLN1 KMT2A KIF5A MAPKBP1 WDR62	1.16e-05	196	123	8	3936_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; HL60; HG-U133A	RARS1 PSMD1 IFI16 FCHSD2 KMT2A MAPKBP1 NIPBL GPN3	1.29e-05	199	123	8	2032_DN
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A	NDST1 AHI1 EZH1 RFX2 TIAM1 KMT2A ADAM2 MMP14	1.29e-05	199	123	8	2109_UP
Drug	PBDA	GRM1 GRM4 GRM5 GRM7	1.99e-05	30	123	4	CID000004408
Drug	alpha-methyl-4-carboxyphenylglycine	GRM1 GRM4 GRM5 GRM7	2.59e-05	32	123	4	CID000001222
Drug	xanthanoic acid	GRM1 GRM5	2.89e-05	2	123	2	CID000065736
Drug	1-aminoindan-1,5-dicarboxylic acid	GRM1 GRM4 GRM5 GRM7	2.94e-05	33	123	4	CID000002071
Drug	AMN082	GRM1 GRM5 GRM7	3.27e-05	12	123	3	CID001894360
Drug	CPPG	GRM1 GRM4 GRM5 GRM7	3.32e-05	34	123	4	CID000002878
Drug	1m5d	GRM1 GRM4 GRM5 GRM7	3.73e-05	35	123	4	CID000447082
Drug	benzyloxyaspartate	GRM1 GRM4 GRM5 GRM7	4.67e-05	37	123	4	CID004133412
Drug	AC1L9FMM	GRM1 GRM4 GRM5 GRM7 ABCD2	4.75e-05	73	123	5	CID000444055
Drug	L-BMAA	GRM1 GRM4 GRM5 GRM7	5.19e-05	38	123	4	CID000028558
Drug	4CPG	GRM1 GRM4 GRM5 GRM7	5.19e-05	38	123	4	CID000005115
Drug	4-aminopyrrolidine-2,4-dicarboxylate	GRM1 GRM4 GRM5 GRM7	5.76e-05	39	123	4	CID003331970
Drug	DETC-MeSO	GRM1 GRM4 GRM5 GRM7	5.76e-05	39	123	4	CID003035711
Drug	2-amino-3-phosphonopropionic acid	GRM1 GRM4 GRM5 GRM7 GRHL1	5.77e-05	76	123	5	CID000003857
Drug	L000369	GRM1 GRM4 GRM5 GRM7	7.04e-05	41	123	4	CID003931705
Drug	AC1NNRU4	GRM1 GRM4 GRM5 GRM7	7.04e-05	41	123	4	CID005126051
Drug	U-U-U	MATK RPS15 PSMD3 FARSA	7.04e-05	41	123	4	CID005289515
Drug	butenafine	GRM1 GRM4 GRM5 GRM7	7.74e-05	42	123	4	CID000002484
Drug	LY341495	GRM1 GRM4 GRM5 GRM7	8.50e-05	43	123	4	CID006324636
Drug	Joro spider toxin	GRM1 GRM4 GRM5 GRM7	8.50e-05	43	123	4	CID000119582
Drug	fenobam	GRM1 GRM5	8.65e-05	3	123	2	CID000162834
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7	8.65e-05	3	123	2	CID000068481
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	A2M FLNC AHI1 IDUA RFX2 FBLN1 SNRNP200	8.75e-05	193	123	7	5998_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	NDST1 ARHGAP35 EZH1 GRM4 KLHL22 TIAM1 MMP14	8.75e-05	193	123	7	4240_DN
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A	SZT2 ARHGAP35 GRM1 GRM4 FBLN1 ADAM2 MMP14	9.33e-05	195	123	7	4250_DN
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A	A2M NDST1 AHI1 KCNAB2 SORCS3 MMP14 CDH18	9.33e-05	195	123	7	5990_UP
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	NDST1 SZT2 KCNAB2 ARHGAP35 IDUA SPTBN4 SORCS3	9.63e-05	196	123	7	3171_UP
Drug	Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	A2M NDST1 SLC43A1 GBP1 GRM1 IDUA RFX2	1.03e-04	198	123	7	5988_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	AHI1 ARHGAP35 EZH1 NEK1 TIAM1 DTX4 WDR62	1.03e-04	198	123	7	7003_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A	AHI1 RARS1 SLC43A1 KCNAB2 NSD1 GBP1 MMP14	1.03e-04	198	123	7	2085_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; PC3; HT_HG-U133A	NDST1 CPM GRM1 KLHL22 FBLN1 ADAM2 MMP14	1.03e-04	198	123	7	4230_DN
Drug	Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; HL60; HG-U133A	NDST1 MED6 SLC43A1 FBXL5 FBLN1 MAPKBP1 NIPBL	1.03e-04	198	123	7	1553_DN
Drug	memantine	CPM GRM1 GRM4 GRM5 GRM7	1.04e-04	86	123	5	CID000004054
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	KCNAB2 ARHGAP35 PCGF3 KLHL22 FBLN1 ADAM2 MMP14	1.06e-04	199	123	7	4562_DN
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	NDST1 RARS1 CPM ARHGAP35 FBXL5 FER MAPKBP1	1.06e-04	199	123	7	1528_DN
Drug	IPSP	SPAG9 GRM1 GRM4 GRM5 GRM7	1.10e-04	87	123	5	CID000022083
Drug	cysteine sulfinic acid	GRM1 GRM4 GRM5 GRM7	1.11e-04	46	123	4	CID000000109
Drug	AC1L1R04	CYP2A6 COQ6 NSD1 HGS	1.21e-04	47	123	4	CID000008439
Drug	hexachlorophene	GRM1 GRM4 GRM5 GRM7 F11	1.29e-04	90	123	5	CID000003598
Drug	methylenecyclopropylglycine	GRM1 GRM4 GRM5 GRM7	1.42e-04	49	123	4	CID000441452
Drug	L-CCG-I	GRM1 GRM4 GRM5 GRM7	1.54e-04	50	123	4	CID000001271
Drug	LY354740	GRM1 GRM4 GRM5 GRM7	1.67e-04	51	123	4	CID000114827
Drug	3H-MA	COQ6 KEL	1.72e-04	4	123	2	CID000194573
Drug	AC1L1EKQ	GRM1 GRM4 GRM5 GRM7	1.80e-04	52	123	4	CID000002834
Drug	N-Ac-D-E	GRM1 GRM4 GRM5 GRM7	1.94e-04	53	123	4	CID000005255
Drug	2-phenylglycine	GRM1 GRM4 GRM5 GRM7	2.24e-04	55	123	4	CID000003866
Disease	primary autosomal recessive microcephaly 2 with or without cortical malformations (implicated_via_orthology)	MAPKBP1 WDR62	1.67e-05	2	121	2	DOID:0070293 (implicated_via_orthology)
Disease	hemolytic anemia (implicated_via_orthology)	A2M G6PD	1.67e-05	2	121	2	DOID:583 (implicated_via_orthology)
Disease	Adenocarcinoma of large intestine	PMS1 MATK ROR2 CDC42BPB TNNI3K	4.84e-05	96	121	5	C1319315
Disease	Attention Deficit Disorder	GRM1 GRM5 GRM7	9.78e-05	22	121	3	C0041671
Disease	Minimal Brain Dysfunction	GRM1 GRM5 GRM7	9.78e-05	22	121	3	C1321905
Disease	Intellectual Disability	NDST1 AHI1 RARS1 NSD1 ERLIN2 KCNQ5 KIF5A CTNNA2 WDR62	9.81e-05	447	121	9	C3714756
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM1 GRM4 GRM5	1.12e-04	23	121	3	C0393672
Disease	Epilepsy, Lateral Temporal	GRM1 GRM4 GRM5	1.12e-04	23	121	3	C0393682
Disease	Uncinate Epilepsy	GRM1 GRM4 GRM5	1.12e-04	23	121	3	C0014558
Disease	Epilepsy, Temporal Lobe	GRM1 GRM4 GRM5	1.12e-04	23	121	3	C0014556
Disease	Attention deficit hyperactivity disorder	GRM1 GRM5 GRM7	1.28e-04	24	121	3	C1263846
Disease	Colorectal Carcinoma	CYP2A6 FLNC PAK6 GRM1 TNNI3K KCNQ5 TIAM1 RHPN2 POLD3 ABCD2 SNRNP200	1.53e-04	702	121	11	C0009402
Disease	Weaver syndrome	NSD1 KMT2A	1.65e-04	5	121	2	C0265210
Disease	Profound Mental Retardation	NDST1 AHI1 NSD1 ERLIN2 WDR62	2.77e-04	139	121	5	C0020796
Disease	Mental Retardation, Psychosocial	NDST1 AHI1 NSD1 ERLIN2 WDR62	2.77e-04	139	121	5	C0025363
Disease	Mental deficiency	NDST1 AHI1 NSD1 ERLIN2 WDR62	2.77e-04	139	121	5	C0917816
Disease	theobromine measurement	CYP2A6 CPM	4.59e-04	8	121	2	EFO_0021179
Disease	Cornelia De Lange Syndrome	KMT2A NIPBL	4.59e-04	8	121	2	C0270972
Disease	3-hydroxypropylmercapturic acid measurement	ISOC1 GPAM CPM PAK6 GRM7 LRP1B KMT2A	6.40e-04	352	121	7	EFO_0007014
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7	1.07e-03	12	121	2	EFO_0007794
Disease	lower face morphology measurement	ROR2 RFX2 LRP1B ANAPC1	1.07e-03	109	121	4	EFO_0010948
Disease	Small cell carcinoma of lung	PAK6 FER KMT2A	1.43e-03	54	121	3	C0149925
Disease	Malformations of Cortical Development	NDST1 WDR62	1.47e-03	14	121	2	C1955869
Disease	Spastic Paraplegia, Hereditary	ERLIN2 KIF5A	1.47e-03	14	121	2	C0037773
Disease	Cortical Dysplasia	NDST1 WDR62	1.47e-03	14	121	2	C0431380
Disease	diffuse idiopathic skeletal hyperostosis	ROR2 POLD3	1.69e-03	15	121	2	EFO_0007236
Disease	shigellosis	C1orf141 MPP7	1.93e-03	16	121	2	EFO_0005585
Disease	pancreatitis	HECTD4 MORC4	1.93e-03	16	121	2	EFO_0000278
Disease	Amyotrophic lateral sclerosis	SPG11 FIG4	2.18e-03	17	121	2	cv:C0002736
Disease	factor XI measurement, Ischemic stroke	HECTD4 F11	2.18e-03	17	121	2	EFO_0004694, HP_0002140
Disease	venous thromboembolism, fibrinogen measurement	HECTD4 F11 TTC17	2.66e-03	67	121	3	EFO_0004286, EFO_0004623
Disease	cystathionine measurement	DOK6 CTNNA2	2.72e-03	19	121	2	EFO_0010474
Disease	emphysema pattern measurement	CYP2A6 VWA8	2.72e-03	19	121	2	EFO_0005850
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7	2.72e-03	19	121	2	EFO_0007872
Disease	pulmonary arterial hypertension	PDE1A TMEM217	3.65e-03	22	121	2	EFO_0001361
Disease	cotinine measurement	CYP2A6 CTNNA2	3.99e-03	23	121	2	EFO_0007813
Disease	granulocyte count	AHI1 HECTD4 PSMD3 PCGF3 IFI16	4.02e-03	254	121	5	EFO_0007987
Disease	unipolar depression	CPM GRM5 GRM7 CDC42BPB ANKRD27 TRMT10C KCNQ5 FIG4 FER SORCS3 SNRNP200 CDH18	4.02e-03	1206	121	12	EFO_0003761

Protein segments in the cluster

Peptide	Gene	Start	Entry
NMERIYHEFQETVGL	EPG5	1451	Q9HCE0
KQFVGYLDKAVIHEM	C1orf141	326	Q5JVX7
YMEAVIHEIQRFGDV	CYP2A6	351	P11509
IAFYRGHKVEMKQLQ	ABCD2	306	Q9UBJ2
HVAQQEAEMFKRYNG	AHI1	921	Q8N157
EPQQDFAKYIEMHVI	ADAM2	171	Q99965
VQFVIDAVYAMGHAL	GRM4	406	Q14833
YIVENDVIMHALTKQ	COQ6	141	Q9Y2Z9
DRVFKQFVQAMVEHG	ABHD3	391	Q8WU67
DMEVGITIQHAYEKQ	DTX4	106	Q9Y2E6
VEYMAKVHALEQVSQ	BFSP2	116	Q13515
TLVVADAKMVEYHGQ	ADAMTS7	246	Q9UKP4
YEMKLHTEAQIQEEG	A2M	316	P01023
VVHYLAMALFQIEQG	BAZ1A	1076	Q9NRL2
YIREGHEKQADIMIF	MMP14	166	P50281
QYIGHDRTMQDIVYK	PCGF3	66	Q3KNV8
KAIVMFEGRHQFEEL	NSD1	381	Q96L73
IYRIDHYLGKEMVQN	G6PD	196	P11413
QHLQDVDIEPYVSKM	SPAG9	1121	O60271
GHIKRMQEVYNFNAI	LTA4H	516	P09960
VQYVVDHAMKIVFLN	ANAPC1	236	Q9H1A4
NLMKQAVEIYVHHEI	ANKRD27	206	Q96NW4
NVPTVDIHMKQVGYE	PLOD3	606	O60568
NEVVIMRDYQHFNVV	PAK6	451	Q9NQU5
SLYGDQIDMHRKFVV	ISOC1	56	Q96CN7
HYIMVKGSIQQEELT	nan	96	O00370
IQHQYLMPENVVEEK	NRBP2	321	Q9NSY0
HVQDSKMGFVINAIY	GRM5	391	P41594
VVHMKVYDKEAQQGS	LRP1B	1821	Q9NZR2
YIVMEHVSKGNLVNF	MATK	301	P42679
KILHLVMADGAYQED	NEK1	1241	Q96PY6
EIMKEGKQFHRIVTY	NUDT19	331	A8MXV4
QEQMVELKYSHLFIG	CFAP65	1251	Q6ZU64
VKDVIEQYSAGHLDM	KCNQ5	546	Q9NR82
NKMLEYLVTGGQEHE	SLC43A1	326	O75387
QHMFVLEQEEYKREG	MYH7B	536	A7E2Y1
GEEQHTVDKLVNMTY	NEK10	176	Q6ZWH5
ALHVYNEVMSVGQKY	PDPR	686	Q8NCN5
IVHAVQAGIFVERMY	PDE1A	121	P54750
EVYVKHMGNRVYNVT	FLNC	2681	Q14315
MESQYGHLFDKIIIN	MPP7	531	Q5T2T1
QLVEIDKKYAGFIHM	NIPBL	2341	Q6KC79
MVQKFLGVTNTIDYH	NDST1	791	P52848
ETIYQGIKHAVVMFQ	LAMP3	316	Q9UQV4
AAVQKAIAHYEQQMG	GBP1	326	P32455
VEKAIAHYEQQMGQK	GBP2	326	P32456
LVETYGKIMNHEERF	CDC42BPB	286	Q9Y5S2
INLEFLKAHTMYQVG	HECTD4	3871	Q9Y4D8
EYHMFQREKVEVQLP	KCNAB2	216	Q13303
VAQVAEITYGQKVME	ERLIN2	221	O94905
HAVLKLEMNYVVGGV	FBLN1	671	P23142
GILVNMDDNIVKHYS	GRHL1	581	Q9NZI5
MEQEEVLIHGVSYNA	KLHL22	86	Q53GT1
VKNVIYHAVKDAVAM	KDM3A	1296	Q9Y4C1
MNIVLQHIDFAIQYG	GPN3	241	Q9UHW5
IHIINAEMENYEAGV	CTNNA2	551	P26232
NYHRQEGMEAFLKTV	CPM	21	P14384
FQTREGEMIYQKVHS	DOK6	211	Q6PKX4
DAKVMDGYENIIVHT	EFCAB7	541	A8K855
KKSYIGVHQQIEAEM	FER	111	P16591
GHAIYKVEDTNMIYI	FIG4	121	Q92562
YMEAVIHEIQRFGDV	CYP2A7	351	P20853
MYHEILGQVKSVFLQ	CCDC13	691	Q8IYE1
FGVQEIIIHDQYKMA	F11	461	P03951
VTYAAMVVKVIAQHQ	IDUA	316	P35475
LKGLEVINDYHFRMV	IFI16	11	Q16666
AKYIVSVGYQHDMIV	MAPKBP1	146	O60336
HYSVVIQAKDMAGQV	CDH18	231	Q13634
QVYHACAMQIVKDVL	KIF5A	61	Q12840
GKVQFVIDAVYAMAH	GRM7	406	Q14831
DGQKHIVIFAMRKIY	KMT2A	3921	Q03164
GKSQMYVQHRVAEAF	HYAL1	256	Q12794
MHEQIENEYIIGLLQ	FBXL5	56	Q9UKA1
VNIMKALDGNVYDHL	FCHSD2	231	O94868
HEGVLNIDDYKIQMN	GRM1	501	Q13255
MELFQAKDHYILQQG	INPP5F	1	Q9Y2H2
DIQDIIYRMKHQFGN	PMS1	896	P54277
DLYGMAVKVTIVHNN	NEURL4	471	Q96JN8
EYQLQVTLEMQDGHV	CDH16	91	O75309
NQMVGIEYILLHAQE	MED6	61	O75586
ADMIIYVVDNGQSVH	RARS1	401	P54136
TYHGQQFLEIKMAER	SZT2	2791	Q5T011
HVNVTFVDYGDREMV	TDRD6	846	O60522
ELVGHKVNLQMVYDS	FARSA	476	Q9Y285
QKIHIDVLEEMGYNS	SAMD8	76	Q96LT4
FYVLEQQHVGLAVDM	NBPF10	1636	Q6P3W6
YVLEQQHVGLAVDMD	NBPF10	1881	Q6P3W6
FYVLEQQHVGLAVDM	NBPF10	2856	Q6P3W6
YVLEQQHVGLAVDMD	NBPF10	3101	Q6P3W6
VDVVMNLQFHYIEKL	RFX2	381	P48378
YAQVQHDKEQEMIGS	SORCS3	1156	Q9UPU3
YVLFIQERDVHKGMF	GPAM	111	Q9HCL2
HMGYRQAEFQILKAE	MORC4	831	Q8TE76
DMVGYAQETQHEKIL	PSMD1	531	Q99460
IREHVYNGQVMETFV	SETMAR	196	Q53H47
DFVHLVAQIAAGMEY	ROR2	591	Q01974
GVHVNQAKQMLYDYV	POLD3	31	Q15054
SVYMDIYGKHQKQII	ARHGAP35	471	Q9NRY4
KVGEVYQQLHAAMSQ	RHPN2	316	Q8IUC4
MKKNIYGNIEDLVVH	AGPS	321	O00116
YGNIEDLVVHIKMVT	AGPS	326	O00116
VEKLYLGHFQENMQI	SPG11	796	Q96JI7
TFNQVEIKPEMIGHY	RPS15	101	P62841
QLHEYNDIKDVGQML	SWI5	196	Q1ZZU3
HVLFMQENKYKEAIG	TTC30B	466	Q8N4P2
INHEKGYVQSKEMID	PSMD3	451	O43242
AEGAAEVVQIMVHYQ	ARHGAP40	451	Q5TG30
INEMQKIHEEFGAVF	TIAM1	1231	Q13009
LKEVVLGMFYLHDQN	RIPK3	121	Q9Y572
TVGQIVHYIMKNEAN	RELL1	116	Q8IUW5
INNYDGKVHGEEEMI	EZH1	151	Q92800
KVVQDTYQIMKVEGH	HGS	126	O14964
SVEVLMNYHQGLKTE	SPTBN4	1976	Q9H254
KVGEVYQQLHAAMSQ	RHPN2P1	231	A8MT19
NMVTGRIEYVEVFHA	PKHD1L1	2451	Q86WI1
VNHFTLGNVYVAMEE	TTC17	1086	Q96AE7
SQKAEVIMNYHVGET	SF3B3	1086	Q15393
AIQMVLEEKFVYKHN	SLC35F6	191	Q8N357
KVVYVENDIQHLQDM	WDR62	461	O43379
EIVYEKIMEHAGKNQ	SNRNP200	706	O75643
VIIMDTQYYNGKIHA	SNRNP200	1661	O75643
QYELFAVIAHVGMAD	USP41	301	Q3LFD5
TSHGKVYIVMELAVQ	TSSK1B	81	Q9BXA7
HVLFMQENKYKEAIG	TTC30A	466	Q86WT1
QYELFAVIAHVGMAD	USP18	301	Q9UMW8
IGVQLQEHSYLEKGM	ZNF407	801	Q9C0G0
VDMYLIFEQKHLGNG	TMEM217	26	Q8N7C4
VNLSSMEDGIKHVYQ	SORCS1	846	Q8WY21
MEDGIKHVYQNVGIF	SORCS1	851	Q8WY21
DVLFYDNIQHVIVME	VWA8	751	A3KMH1
IAVDVAKGMEYLHNL	TNNI3K	566	Q59H18
KYGIYAVENEHMNRL	VTI1B	111	Q9UEU0
NVMTTFRHDKVYVIG	TRMT10C	296	Q7L0Y3
VVHDVEYLKNMSQLV	KEL	336	P23276